A study published in Nature’s new open-access journal NPJ Precision Oncology reports that researchers tested the prognostic value of a clonal gene signature from malignant pleural mesothelioma tumor samples and found them to have high prognostic values and reproducibility. The results suggest that the information will help physicians treating patients with the rare form of cancer will
Dr. Sandeep J. Khandar is a cardiothoracic and thoracic surgeon and member of the Virginia Cancer Specialists Physicians Group which practices within the INOVA Health System in Northern Virginia. Board-certified in Cardiothoracic Thoracic and General Surgery, he has a special interest in the management of lung cancer, malignant pleural mesothelioma, and other thoracic malignancies using
Dr. Miguel Alvelo-Rivera is a thoracic surgical oncologist at Henry Ford Health in Detroit, Michigan. He specializes in the use of minimally invasive surgical procedures to treat patients with lung cancer, esophageal cancer, and other thoracic malignancies including malignant pleural mesothelioma. Dr. Alvelo-Rivera works as part of a multidisciplinary team that includes medical oncologists, pulmonologists,
Dr. John R. Roberts is a board-certified thoracic surgeon at Continuity Care, affiliated with Delray Medical Center, JFK Hospital, Bethesday Hospital East, and Boca Raton Regional Hospital in Boca Raton, Florida. His clinical interests center on the use of minimally invasive and robotic surgical techniques for the treatment of patients diagnosed with lung cancer, esophageal
Dr. David S. Schrump is the Surgical Chief of the Thoracic Surgery Branch of the National Cancer Institute’s Center for Cancer Research. In this role, he oversees clinical and translational research about thoracic malignancies, particularly lung and esophageal cancers and malignant pleural mesotheliomas. Dr. Schrump pioneered the development of epigenomic therapies for thoracic cancers and
Dr. Evan S. K. Ong is a general surgeon and surgical oncologist at the Swedish Medical Center in Seattle, Washington. He specializes in the use of state-of-the-art surgical techniques, including minimally invasive and robotic surgery for hepatic and pancreatic tumors, hyperthermic intraperitoneal chemoperfusion (HIPEC) for peritoneal mesothelioma and other surface malignancies that have disseminated to
Dr. Mark Richard Dylewski is a thoracic surgeon at the Baptist Health South Florida and its affiliated Miami Cancer Institute in Miami, Florida. He holds the titles of Chairman of Thoracic Surgery and Director of Robotic Thoracic Surgery at Baptist Health South Florida and Chief of Thoracic Surgery at Miami Cancer Institute. Dr. Dylewski has
Dr. Gary M. Hochheiser is the Director of Thoracic Surgery and Thoracic Oncology at Maine Medical Center and the Medical Director for the facility’s Lung Screening Program. He specializes in the use of minimally invasive procedures for the treatment of malignant pleural mesothelioma, lung cancer, and esophageal cancer, as well as benign thoracic diseases. He
Dr. Anthony R. Lanfranco is an interventional pulmonologist and critical care specialist at Penn Medicine in Philadelphia. He specializes in numerous procedures integral to the care of patients with malignant pleural mesothelioma, lung cancer, and other pleural and lung diseases, including airway stenting, bronchial stenosis, bronchoscopy, cryotherapy, endoscopic lung volume reduction, and laser bronchoscopy. Education
Dr. Pettiford is a surgical oncologist with a focus on thoracic surgery at Ochsner M.D. Anderson Cancer Center in New Orleans, Louisiana. He has extensive experience in the treatment of malignant pleural mesothelioma and the use of robotic surgery for the treatment of lung cancer, benign lung disease, and esophageal cancer as well as benign